Show simple item record

dc.contributor.authorWinje, Brita Askeland
dc.contributor.authorOftung, Fredrik
dc.contributor.authorKorsvold, Gro Ellen
dc.contributor.authorMannsåker, Turid
dc.contributor.authorLy, Ingvild Nesthus
dc.contributor.authorHarstad, Ingunn
dc.contributor.authorDyrhol-Riise, Anne Ma
dc.contributor.authorHeldal, Einar
dc.date.accessioned2015-09-30T07:25:59Z
dc.date.accessioned2015-10-28T10:24:17Z
dc.date.available2015-09-30T07:25:59Z
dc.date.available2015-10-28T10:24:17Z
dc.date.issued2008
dc.identifier.citationBMC Infectious Diseases 2008, 8nb_NO
dc.identifier.issn1471-2334
dc.identifier.urihttp://hdl.handle.net/11250/2358276
dc.description.abstractBackground: In Norway, screening for tuberculosis infection by tuberculin skin test (TST) has been offered for several decades to all children in 9th grade of school, prior to BCG-vaccination. The incidence of tuberculosis in Norway is low and infection with M. tuberculosis is considered rare. QuantiFERON®TB Gold (QFT) is a new and specific blood test for tuberculosis infection. So far, there have been few reports of QFT used in screening of predominantly unexposed, healthy, TST-positive children, including first and second generation immigrants. In order to evaluate the current TST screening and BCG-vaccination programme we aimed to (1) measure the prevalence of QFT positivity among TST positive children identified in the school based screening, and (2) measure the association between demographic and clinical risk factors for tuberculosis infection and QFT positivity. Methods: This cross-sectional multi-centre study was conducted during the school year 2005–6 and the TST positive children were recruited from seven public hospitals covering rural and urban areas in Norway. Participation included a QFT test and a questionnaire regarding demographic and clinical risk factors for latent infection. All positive QFT results were confirmed by re-analysis of the same plasma sample. If the confirmatory test was negative the result was reported as non-conclusive and the participant was offered a new test. Results: Among 511 TST positive children only 9% (44) had a confirmed positive QFT result. QFT positivity was associated with larger TST induration, origin outside Western countries and known exposure to tuberculosis. Most children (79%) had TST reactions in the range of 6–14 mm; 5% of these were QFT positive. Discrepant results between the tests were common even for TST reactions above 15 mm, as only 22 % had a positive QFT. Conclusion: The results support the assumption that factors other than tuberculosis infection are widely contributing to positive TST results in this group and indicate the improved specificity of QFT for latent tuberculosis. Our study suggests a very low prevalence of latent tuberculosis infection among 9th grade school children in Norway. The result will inform the discussion in Norway of the usefulness of the current TST screening and BCG-policy.nb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.titleSchool based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assaynb_NO
dc.typeJournal articlenb_NO
dc.typePeer revieweden_GB
dc.date.updated2015-09-30T07:25:59Z
dc.source.volume8nb_NO
dc.source.journalBMC Infectious Diseasesnb_NO
dc.identifier.doi10.1186/1471-2334-8-140
dc.identifier.cristin360940
dc.description.localcode© 2008 Winje et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record